6-Month Buy/Sell Trend
Buys
Sells
▶
2026-03-02
▼ 6 sells
· $1.0M
6 other
⚡ 6 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Mackin James P | President & CEO | A | 116,948 | $0 | $0 | Mar 4 | |
| Berry Lance A | EVP, COO, CFO & Treasurer | A | 40,874 | $0 | $0 | Mar 4 | |
| Davis John E | Chief Commercial Officer | A | 28,845 | $0 | $0 | Mar 4 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | A | 21,838 | $0 | $0 | Mar 4 | |
| Holloway Jean F | SVP, General Counsel | A | 27,795 | $0 | $0 | Mar 4 | |
| Horton Amy | VP, Chief Accounting Officer | A | 7,475 | $0 | $0 | Mar 4 | |
| Davis John E | Chief Commercial Officer | ▼ Sell | 2,784 | $38 | $106K | Mar 3 | |
| Berry Lance A | EVP, COO, CFO & Treasurer | ▼ Sell | 5,178 | $38 | $197K | Mar 3 | |
| Holloway Jean F | SVP, General Counsel | ▼ Sell | 2,183 | $38 | $83K | Mar 3 | |
| Mackin James P | President & CEO | ▼ Sell | 14,911 | $38 | $567K | Mar 3 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | ▼ Sell | 1,513 | $38 | $58K | Mar 3 | |
| Horton Amy | VP, Chief Accounting Officer | ▼ Sell | 641 | $38 | $24K | Mar 3 |
▶
2026-03-03
▼ 6 sells
· $1.3M
⚡ 6 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Mackin James P | President & CEO | ▼ Sell | 17,887 | $38 | $676K | Mar 4 | |
| Berry Lance A | EVP, COO, CFO & Treasurer | ▼ Sell | 6,316 | $38 | $239K | Mar 4 | |
| Davis John E | Chief Commercial Officer | ▼ Sell | 4,573 | $38 | $173K | Mar 4 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | ▼ Sell | 2,149 | $38 | $81K | Mar 4 | |
| Holloway Jean F | SVP, General Counsel | ▼ Sell | 3,843 | $38 | $145K | Mar 4 | |
| Horton Amy | VP, Chief Accounting Officer | ▼ Sell | 901 | $38 | $34K | Mar 4 |
▶
2026-03-04
▼ 1 sell
· $341K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Holloway Jean F | SVP, General Counsel | ▼ Sell | 8,962 | $38 | $341K | Mar 4 |
▶
2026-02-23
▼ 6 sells
· $1.4M
⚡ 6 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Davis John E | Chief Commercial Officer | ▼ Sell | 3,773 | $38 | $142K | Feb 25 | |
| Berry Lance A | EVP, COO, CFO & Treasurer | ▼ Sell | 4,981 | $38 | $187K | Feb 25 | |
| Mackin James P | President & CEO | ▼ Sell | 20,962 | $38 | $788K | Feb 25 | |
| Holloway Jean F | SVP, General Counsel | ▼ Sell | 3,079 | $38 | $116K | Feb 25 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | ▼ Sell | 2,423 | $38 | $91K | Feb 25 | |
| Horton Amy | VP, Chief Accounting Officer | ▼ Sell | 1,731 | $38 | $65K | Feb 25 |
▶
2026-02-24
▼ 6 sells
· $866K
5 other
⚡ 6 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Davis John E | Chief Commercial Officer | ▼ Sell | 2,075 | $36 | $74K | Feb 25 | |
| Davis John E | Chief Commercial Officer | A | 20,438 | $0 | $0 | Feb 25 | |
| Berry Lance A | EVP, COO, CFO & Treasurer | ▼ Sell | 4,485 | $36 | $160K | Feb 25 | |
| Berry Lance A | EVP, COO, CFO & Treasurer | A | 37,482 | $0 | $0 | Feb 25 | |
| Mackin James P | President & CEO | ▼ Sell | 13,936 | $36 | $497K | Feb 25 | |
| Mackin James P | President & CEO | A | 97,030 | $0 | $0 | Feb 25 | |
| Holloway Jean F | SVP, General Counsel | ▼ Sell | 1,668 | $36 | $60K | Feb 25 | |
| Holloway Jean F | SVP, General Counsel | A | 20,085 | $0 | $0 | Feb 25 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | ▼ Sell | 1,259 | $36 | $45K | Feb 25 | |
| Horton Amy | VP, Chief Accounting Officer | ▼ Sell | 830 | $36 | $30K | Feb 25 | |
| Horton Amy | VP, Chief Accounting Officer | A | 5,658 | $0 | $0 | Feb 25 |
▶
2025-12-15
▼ 1 sell
· $226K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Davis John E | Chief Commercial Officer | ▼ Sell | 5,000 | $45 | $226K | Dec 17 |
▶
2025-12-08
▼ 1 sell
· $203K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Horton Amy | VP, Chief Accounting Officer | ▼ Sell | 4,572 | $44 | $203K | Dec 9 |
▶
2025-12-03
▼ 3 sells
· $1.7M
2 other
⚡ 2 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Holloway Jean F | SVP, General Counsel | ▼ Sell | 2,048 | $45 | $93K | Dec 4 | |
| Holloway Jean F | SVP, General Counsel | ▼ Sell | 5,267 | $45 | $239K | Dec 4 | |
| Mackin James P | President & CEO | M | 30,921 | $30 | $916K | Plan | Dec 4 |
| Mackin James P | President & CEO | ▼ Sell | 30,921 | $45 | $1.4M | Plan | Dec 4 |
| Mackin James P | President & CEO | M | 30,921 | $0 | $0 | Plan | Dec 4 |
▶
2025-12-02
▼ 1 sell
· $1.4M
2 other
▶
2025-12-01
1 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Horton Amy | VP, Chief Accounting Officer | G | 750 | $0 | $0 | Dec 2 |
▶
2025-11-20
▼ 3 sells
· $675K
4 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Stanton Marshall S. | SVP, Clinical & MD Affair | ▼ Sell | 11,888 | $44 | $525K | Nov 24 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M | 2,033 | $18 | $37K | Nov 24 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | ▼ Sell | 2,033 | $44 | $90K | Nov 24 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M | 1,355 | $11 | $15K | Nov 24 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | ▼ Sell | 1,355 | $44 | $60K | Nov 24 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M | 2,033 | $0 | $0 | Nov 24 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M | 1,355 | $0 | $0 | Nov 24 |
▶
2025-11-21
▼ 4 sells
· $2.1M
4 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Stanton Marshall S. | SVP, Clinical & MD Affair | M | 20,301 | $18 | $374K | Nov 24 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | ▼ Sell | 14,586 | $45 | $655K | Nov 24 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | ▼ Sell | 5,715 | $45 | $259K | Nov 24 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M | 27,075 | $11 | $299K | Nov 24 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | ▼ Sell | 18,705 | $45 | $840K | Nov 24 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | ▼ Sell | 8,370 | $45 | $380K | Nov 24 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M | 20,301 | $0 | $0 | Nov 24 | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M | 27,075 | $0 | $0 | Nov 24 |
▶
2025-11-18
▼ 1 sell
· $189K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Hoff Elizabeth A | — | ▼ Sell | 4,200 | $45 | $189K | Nov 19 |
▶
2025-11-17
▼ 3 sells
· $852K
4 other
⚡ 3 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Horton Amy | VP, Chief Accounting Officer | ▼ Sell | 6,000 | $46 | $274K | Nov 18 | |
| Davis John E | Chief Commercial Officer | M | 6,394 | $30 | $189K | Plan | Nov 18 |
| Davis John E | Chief Commercial Officer | ▼ Sell | 6,394 | $45 | $289K | Plan | Nov 18 |
| Davis John E | Chief Commercial Officer | M | 6,394 | $0 | $0 | Plan | Nov 18 |
| Holloway Jean F | SVP, General Counsel | M | 6,394 | $30 | $189K | Plan | Nov 18 |
| Holloway Jean F | SVP, General Counsel | ▼ Sell | 6,394 | $45 | $289K | Plan | Nov 18 |
| Holloway Jean F | SVP, General Counsel | M | 6,394 | $0 | $0 | Plan | Nov 18 |
▶
2025-11-14
▼ 2 sells
· $573K
4 other
⚡ 2 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Davis John E | Chief Commercial Officer | M | 6,393 | $30 | $189K | Plan | Nov 18 |
| Davis John E | Chief Commercial Officer | ▼ Sell | 6,393 | $45 | $286K | Plan | Nov 18 |
| Davis John E | Chief Commercial Officer | M | 6,393 | $0 | $0 | Plan | Nov 18 |
| Holloway Jean F | SVP, General Counsel | M | 6,393 | $30 | $189K | Plan | Nov 18 |
| Holloway Jean F | SVP, General Counsel | ▼ Sell | 6,393 | $45 | $288K | Plan | Nov 18 |
| Holloway Jean F | SVP, General Counsel | M | 6,393 | $0 | $0 | Plan | Nov 18 |
▶
2025-11-13
▼ 5 sells
· $2.5M
⚡ 5 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Stanton Marshall S. | SVP, Clinical & MD Affair | ▼ Sell | 4,993 | $46 | $229K | Nov 14 | |
| Holloway Jean F | SVP, General Counsel | ▼ Sell | 5,761 | $46 | $264K | Nov 14 | |
| Mackin James P | President & CEO | ▼ Sell | 34,210 | $46 | $1.6M | Nov 14 | |
| Davis John E | Chief Commercial Officer | ▼ Sell | 6,563 | $46 | $301K | Nov 14 | |
| Horton Amy | VP, Chief Accounting Officer | ▼ Sell | 3,482 | $46 | $160K | Nov 14 |
▶
2025-11-10
▼ 5 sells
· $1.3M
⚡ 5 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Stanton Marshall S. | SVP, Clinical & MD Affair | ▼ Sell | 2,566 | $45 | $114K | Nov 12 | |
| Horton Amy | VP, Chief Accounting Officer | ▼ Sell | 1,789 | $45 | $80K | Nov 12 | |
| Davis John E | Chief Commercial Officer | ▼ Sell | 3,373 | $45 | $150K | Nov 12 | |
| Mackin James P | President & CEO | ▼ Sell | 17,580 | $45 | $784K | Nov 12 | |
| Holloway Jean F | SVP, General Counsel | ▼ Sell | 2,960 | $45 | $132K | Nov 12 |